Allergan Inc. (AGN), the drugmaker fending off a takeover by Valeant Pharmaceuticals International Inc. (VRX), will cut 1,500 jobs and may use the savings for an acquisition, its chief executive officer said.
Allergan to Lay Off 13% of Workforce, Cut Drug Research
Wall Street Journal
TSX just off record high, Valeant rises
Related articles »